Details for New Drug Application (NDA): 018506
✉ Email this page to a colleague
The generic ingredient in TRINALIN is azatadine maleate; pseudoephedrine sulfate. There are two drug master file entries for this compound. Additional details are available on the azatadine maleate; pseudoephedrine sulfate profile page.
Summary for 018506
Tradename: | TRINALIN |
Applicant: | Schering |
Ingredient: | azatadine maleate; pseudoephedrine sulfate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 1MG;120MG | ||||
Approval Date: | Mar 23, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 018506
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | TRINALIN | azatadine maleate; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 018506-001 | Mar 23, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Schering | TRINALIN | azatadine maleate; pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 018506-001 | Mar 23, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription